trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 1 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions?

Yes. Lowering blood pressure is a well-established strategy for reducing cardiovascular events such as strokes and myocardial infarctions, although the magnitude of benefit in mild or untreated hypertension continues to be refined by ongoing clinical trials.

Verdict: SUPPORTED · 3 sources for, 1 against · Last checked

Evidence for · 3
Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First-Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older.
2026
Angiotensin receptor blocker therapy significantly lowered the risk of myocardial infarction, stroke, heart failure, and mortality compared to calcium channel blockers in older adults.
Get citation
H, N., H, S., T, S., KE, S., F, O., M, M., & H, F. (2026). Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First-Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older.. doi.org. https://doi.org/10.1111/jgs.70463

Evidence against · 1
Pharmacotherapy for mild hypertension.
2026
A Cochrane review update on mild hypertension found that initiating antihypertensive pharmacotherapy may have little to no significant reduction on all-cause mortality or overall cardiovascular events, though it may reduce stroke risk.
Get citation
D, W., JM, W., SP, A., DK, C., F, G., G, G., & A, A. (2026). Pharmacotherapy for mild hypertension.. doi.org. https://doi.org/10.1002/14651858.cd006742.pub4

See more details
More for · 2
Impact of folic acid supplementation on cardiovascular risk among individuals with hemorrhagic stroke: A prospective study.
2026
Combined antihypertensive and folic acid therapy significantly reduced cardiovascular disease and recurrent stroke risk in hypertensive individuals.
Get citation
D, D., Y, S., H, Z., & A, L. (2026). Impact of folic acid supplementation on cardiovascular risk among individuals with hemorrhagic stroke: A prospective study.. doi.org. https://doi.org/10.1097/md.0000000000049415

Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial.
2026
Hypertension guidelines and trials affirm that lowering blood pressure reduces cardiorenal complications including myocardial infarction and stroke.
Get citation
F, L. V., JM, H., P, R., M, L., M, A., B, S., V, M., A, R., A, C., & B, S. (2026). Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial.. doi.org. https://doi.org/10.1136/bmjopen-2026-122192

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work